Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Barnes, Christopher O., West, Anthony P., Huey-Tubman, Kathryn E., Hoffmann, Magnus A.G., Sharaf, Naima G., Hoffman, Pauline R., Koranda, Nicholas, Gristick, Harry B. +15 more·2020·Cell
DOI 10.1016/j.cell.2020.06.025

Cited by (803)

Items 401–500 of 803

  1. Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering
    Gennady M. Verkhivker · 2022 · International Journal of Molecular Sciences
  2. Uncovering the Role of N-Glycan Occupancy on the Cooperative Assembly of Spike and Angiotensin Converting Enzyme 2 Complexes: Insights from Glycoengineering and Native Mass Spectrometry
    Tarick J. El‐Baba, Corinne A. Lutomski, Sean Anthony Burnap, Jani Reddy Bolla, Lindsay A. Baker, Andrew J. Baldwin, Weston B. Struwe, Carol V. Robinson · 2023 · Journal of the American Chemical Society
  3. Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants
    Rui Ming Yin, Johnathan D. Guest, Ghazaleh Taherzadeh, Ragul Gowthaman, Ipsa Mittra, Jane Quackenbush, Brian G. Pierce · 2021 · PLoS Computational Biology
  4. Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies
    Brandon J. Beddingfield, Nicholas J. Maness, Alyssa C. Fears, Jay Rappaport, Pyone P. Aye, Kasi Russell‐Lodrigue, Lara A. Doyle‐Meyers, Robert V. Blair, Ann M. Carias, Patrick J. Madden et al. · 2021 · Frontiers in Cellular and Infection Microbiology
  5. Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations
    Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan · 2022 · International Journal of Molecular Sciences
  6. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
    Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Yu Erica Lee, Pauline R. Hoffman, Susan Ou, Leesa M. Kakutani, Jennifer R. Keeffe, Hung-Jen Wu, Mark R. Howarth, Anthony P. West et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  7. IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
    de Mattos Barbosa, Mayara Garcia, Liu, Hui, Huynh, Daniel, Shelley, Greg, Keller, Evan T., Emmer, Brian T., Sherman, Emily, Ginsburg, David, Kennedy, Andrew A., Tai, Andrew W. et al. · 2021 · JCI Insight
  8. The molecular reach of antibodies crucially underpins their viral neutralisation capacity
    Anna Gesine Huhn, Daniel Allen Nissley, Daniel B. Wilson, Mikhail A. Kutuzov, Robert F. Donat, Tiong Kit Tan, Ying Zhang, Michael I. Barton, Chang Liu, Wanwisa Dejnirattisai et al. · 2025 · Nature Communications
  9. Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
    Emilie Seydoux, Yu-Hsin Wan, Junli Feng, Abigail Wall, Safia Aljedani, Leah J. Homad, Anna J. MacCamy, Connor Weidle, Matthew D. Gray, Lauren Brumage et al. · 2021 · Cell Reports
  10. Analysis of the molecular mechanism of SARS-CoV-2 antibodies
    Dongfu Jin, Jing Wei, Jian Sun · 2021 · Biochemical and Biophysical Research Communications
  11. Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner
    Fatima Amanat, Shirin Strohmeier, Wen-Hsin Lee, Sandhya Bangaru, Andrew B. Ward, Lynda Coughlan, Florian Krammer · 2021 · mBio
  12. A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
    Shugang Qin, Hai Huang, Wen Xiao, Kepan Chen, Xi He, Xiaoshan Tang, Zhiying Huang, Yupei Zhang, Xing Duan, Na Fan et al. · 2023 · Acta Pharmaceutica Sinica B
  13. Spike- and nucleocapsid-based gold colloid assay toward the development of an adhesive bandage for rapid SARS-CoV-2 immune response detection and screening
    Imen Boumar, Muhammedin Deliorman, Pavithra Sukumar, Mohammad Ameen Qasaimeh · 2023 · Microsystems & Nanoengineering
  14. Engineered Ultra-High Affinity Synthetic Antibodies for SARS-CoV-2 Neutralization and Detection
    Tomasz Ślężak, Anthony A. Kossiakoff · 2021 · Journal of Molecular Biology
  15. Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations
    Mohamed A Hendy, Samuel Kaufman, Mauricio Rene Ponga · 2021 · Scientific Reports
  16. Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination
    Dennis J. Schaefer-Babajew, Zijun Wang, Frauke Muecksch, Alice Cho, Raphael Raspe, Brianna A. Johnson, Marie Canis, Justin DaSilva, Víctor Ramos, Martina Turroja et al. · 2022 · medRxiv
  17. Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA
    Raghavan, Sai Sundar Rajan, Dagil, Robert, Lopez-Perez, Mary, Conrad, Julian, Bassi, Maria Rosaria, Quintana, Maria del Pilar, Choudhary, Swati, Gustavsson, Tobias, Wang, Yong, Gourdon, Pontus et al. · 2022 · PLOS Pathogens
  18. Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses
    Pradeepa Pushparaj, Andrea Nicoletto, Xaquín Castro Dopico, Daniel J. Sheward, Sungyong Kim, Simon Ekström, Ben Murrell, Martin Corcoran, Gunilla B. Karlsson Hedestam · 2023 · Frontiers in Virology
  19. Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
    Viviane M. Andrade, Igor Maricic, Richa Kalia, Lauren A Jachimowicz, Olivia Bedoya, Daniel W. Kulp, Laurent M. P. F. Humeau, Trevor R.F. Smith · 2023 · Human Vaccines & Immunotherapeutics
  20. Therapeutic antibodies and alternative formats against SARS-CoV-2
    Rahel R. Winiger, Laurent H. Perez · 2024 · Antiviral Research
  21. Nanobody engineering for SARS-CoV-2 neutralization and detection
    Liina Hannula, Suvi H. Kuivanen, Jonathan Lasham, Ravi Kant, Lauri Kareinen, Mariia S. Bogacheva, Tomas M. Strandin, Tarja A. Sironen, Jussi Hepojoki, Vivek Sharma et al. · 2024 · Microbiology Spectrum
  22. Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2
    Deyong Song, Wenbo Wang, Chuangchuang Dong, Zhenfei Ning, Xiu Liu, Chuan Liu, Guangying Du, Chunjie Sha, Kailin Wang, Jun Lu et al. · 2021 · Communications Biology
  23. Immunoinformatics and Pepscan strategies on the path of a peptide-based serological diagnosis of COVID19
    María Angelita Lorenzo, Diana Pachón, Alexandra Maier, Henry Bermúdez, Sandra Losada, Marilyan Toledo, Flor Helene Pujol, Belkisyolé Alarcón de Noya, Óscar Noya, María Luisa Serrano · 2021 · Journal of Immunological Methods
  24. Immunology of SARS-CoV-2 infections and vaccines
    Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
  25. Stabilization of the SARS-CoV-2 receptor binding domain by protein core redesign and deep mutational scanning
    Alison C. Leonard, Jonathan J. Weinstein, Paul J. Steiner, Annette H. Erbse, Sarel Jacob Fleishman, Timothy A. Whitehead · 2022 · Protein Engineering Design and Selection
  26. Recent advances in immunoassay technologies for the detection of human coronavirus infections
    Danqi Wang, Yuejun Chen, Xiang Shan, Huiting Hu, Yujuan Zhan, Ying Yu, Jingwen Zhang, Pian Wu, Fei yue Liu, Tianhan Kai et al. · 2023 · Frontiers in Cellular and Infection Microbiology
  27. Cross-reactive antibody responses against SARS-CoV-2 and seasonal common cold coronaviruses
    Shelley Klompus, Sigal Leviatan, Thomas J. Vogl, Iris N. Kalka, Anastasia Godneva, Eilat Shinar, Adina Weinberger, Eran Segal · 2020 · medRxiv
  28. Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times
    Thomas Bachelet, Jean-Philippe Bourdenx, C Martinez, Simon Mucha, Philippe Martin-Dupont, Valerie Perier, Antoine Pommereau · 2021 · PLoS ONE
  29. Landscape-Based Protein Stability Analysis and Network Modeling of Multiple Conformational States of the SARS-CoV-2 Spike D614G Mutant: Conformational Plasticity and Frustration-Induced Allostery as Energetic Drivers of Highly Transmissible Spike Variants
    Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan · 2022 · Journal of Chemical Information and Modeling
  30. Neutralizing and enhancing antibodies against SARS-CoV-2
    Yafei Liu, Hisashi Arase · 2022 · Inflammation and Regeneration
  31. Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses
    Yuan Peng, Yongcheng Liu, Yabin Hu, Fangfang Chang, Qian Wu, Jing Yang, Jun Chen, Shishan Teng, Jian Zhang, Rongzhang He et al. · 2022 · Frontiers in Immunology
  32. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
    Siriruk Changrob, Peter Halfmann, Hejun Liu, Jonathan L. Torres, Joshua J.C. McGrath, Gabriel Ozorowski, Lei Li, G. Dewey Wilbanks, Makoto Kuroda, Tadashi Maemura et al. · 2023 · Journal of Clinical Investigation
  33. What makes SARS‐CoV‐2 unique? Focusing on the spike protein
    Jingbo Qian, Shi-Chang Zhang, Fang Wang, Jinming Li, Jiexin Zhang · 2024 · Cell Biology International
  34. A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif
    Hang Su, Jun Zhang, Zhenfei Yi, Sajid Ullah Khan, Mian Peng, Liang Ye, Alan Bao, Han Zhang, Guangli Suo, Qian Li et al. · 2024 · hLife
  35. Direct Mapping of Polyclonal Epitopes in Serum by HDX-MS
    Clint Vorauer, Camila Boniche-Alfaro, Taylor A. Murphree, Tsutomu Matsui, Thomas M Weiss, Bettina C. Fries, Miklós Guttman · 2024 · Analytical Chemistry
  36. The development of neutralizing antibodies against SARS-CoV-2 and their common features
    Liu Daisy Liu, Chaoyang Lian, Leng-Siew Yeap, Fei‐Long Meng · 2020 · Journal of Molecular Cell Biology
  37. Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review 31
    Francesca Levi‐Schaffer, Ario de Marco · 2021 · British Journal of Pharmacology
  38. Monoclonal antibodies capable of binding SARS‐CoV‐2 spike protein receptor‐binding motif specifically prevent GM‐CSF induction
    X. Qiang, Shu Zhu, Jian-Hua Li, Weiqiang Chen, Huan Yang, Ping Wang, K. Tracey, Haichao Wang · 2021 · Journal of Leukocyte Biology
  39. SARS-CoV-2 Neutralizing Antibody Levels Post COVID-19 Vaccination Based on ELISA Method—A Small Real-World Sample Exploration
    Xiaoguang Li, Chao Liang, Xiumei Xiao · 2021 · Vaccines
  40. How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika
    M. Abernathy, K. A. Dam, S. Esswein, C. A. Jette, P. Bjorkman · 2021 · Viruses
  41. Germinal center–mediated broadening of B cell responses to SARS-CoV-2 booster immunization
    Sameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, Wafaa B. Alsoussi, Tamarand L. Darling, Bernadeta Dadonaite, Alesandro Civljak, Stephen C. Horvath, Julian Q. Zhou, Wooseob Kim et al. · 2025 · Science Immunology
  42. Frustration-driven allosteric regulation and signal transmission in the SARS-CoV-2 spike omicron trimer structures: a crosstalk of the omicron mutation sites allosterically regulates tradeoffs of protein stability and conformational adaptability
    Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan · 2022 · Physical Chemistry Chemical Physics
  43. Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
    Michael Schöfbänker, Theresa Günther, Eva Ulla Lorentzen, Marie-Luise Romberg, Marc Tim Hennies, Rieke Neddermeyer, Marlin Maybrit Müller, Alexander Mellmann, Chiara Robin Bojarzyn, Georg Lenz et al. · 2024 · PLoS Pathogens
  44. Point mutations in SARS-CoV-2 variants induce long-range dynamical perturbations in neutralizing antibodies
    Dhiman Ray, Riley Quijano, I. Andricioaei · 2022 · Chemical Science
  45. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS‐CoV‐2 neutralizing activity of sera
    Arantxa Valdivia, Ignacio Torres, Víctor Latorre, Clara Francés‐Gómez, Josep Ferrer, Lorena Forqué, Rosa E. P. Da Costa, Carlos Solano de la Asunción, Dixie Huntley, Roberto Gozalbo‐Rovira et al. · 2020 · Journal of Medical Virology
  46. Epitope mapping of neutralising anti‐SARS‐CoV‐2 monoclonal antibodies: Implications for immunotherapy and vaccine design
    Somayeh Ghotloo, Faezeh Maghsood, Forough Golsaz‐Shirazi, Mohammad Mehdi Amiri, Christiane Moog, Fazel Shokri · 2022 · Reviews in Medical Virology
  47. Would It Be Possible to Stabilize Prefusion SARS-COV-2 Spikes with Ligands?
    Marı́a M. Lorenzo, Rafael Blasco, Julio M. Coll · 2021 · ChemRxiv
  48. Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey
    Leslie Y. T. Leung, Srijit Khan, P. Budylowski, Zhi-Jie Li, S. Goroshko, Yanling Liu, Shilan Dong, J. Carlyle, J. Rini, M. Ostrowski et al. · 2021 · Frontiers in Immunology
  49. Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
    Simone Pecetta, Sven Kratochvil, Yu Kato, Kumaran Vadivelu, Rino Rappuoli · 2022 · Pharmacological Reviews
  50. Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
    Laura Radić, Kwinten Sliepen, Victor C. Yin, Mitch Brinkkemper, Joan Capella-Pujol, Angela I. Schriek, Jonathan L. Torres, Sandhya Bangaru, Judith A. Burger, Meliawati Poniman et al. · 2023 · iScience
  51. SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
    Andrew P. Hederman, Harini Natarajan, Leo Heyndríckx, Kevin K. Ariën, Joshua A. Wiener, Peter F. Wright, Evan M. Bloch, Aaron A.R. Tobian, Andrew D. Redd, Joel N. Blankson et al. · 2023 · Nature Communications
  52. TfrAdmCov: a robust transformer encoder based model with Adam optimizer algorithm for COVID-19 mutation prediction
    Mehmet Burukanlı, Nejat Yumuşak · 2024 · Connection Science
  53. Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach
    Alexander Kwarteng, Ebenezer Asiedu, Augustina Angelina Sylverken, Amma Aboagyewa Larbi, Samuel Asamoah Sakyi, Samuel Opoku Asiedu · 2021 · Infection Genetics and Evolution
  54. Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
    Huimin Guo, Qing Fan, Shuo Song, Senlin Shen, Bing Zhou, Haiyan Wang, Lin Cheng, Xiangyang Ge, Bin Ju, Zheng Zhang · 2022 · Journal of Clinical Virology
  55. Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
    Jennifer Cable, Anthony S. Fauci, William E. Dowling, Stephan Günther, Dennis A. Bente, Pragya Dhruv Yadav, Lawrence C. Madoff, Lin‐Fa Wang, Rahul K. Arora, Maria D. Van Kerkhove et al. · 2022 · Annals of the New York Academy of Sciences
  56. Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
    Hsiao-Ling Chiang, Kang-Hao Liang, Ruei‐Min Lu, Ting-Wen Kuo, Yi‐Ling Lin, Han‐Chung Wu · 2023 · Journal of Biomedical Science
  57. SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes
    Steven C. Wall, Naveenchandra Suryadevara, Changil Kim, Andrea R. Shiakolas, Clinton M. Holt, Emma B Irbe, Perry T. Wasdin, Yukthi P. Suresh, E. Binshtein, Elaine C. Chen et al. · 2023 · Cell Reports Medicine
  58. From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate, Then Clot Blood Cells in Pulmonary and Systemic Microvasculature
    David E. Scheim · 2020 · SSRN Electronic Journal
  59. A high-throughput, automated, cell-free expression and screening platform for antibody discovery
    Andrew C. Hunt, Bastian Vögeli, Weston Kightlinger, Danielle J. Yoesep, Antje Krüger, Michael C. Jewett · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1
    Jialu Shi, Xiaoyu Zhao, Xiaohui Jin, Jiayan Li, Yuanchen Liu, Huan Liu, Ye‐Fan Hu, Zhe Chen, Yuxin Xiao, Lei Wang et al. · 2025 · Nature Communications
  61. Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
    Blanca J. Valdovinos-Navarro, Salvador Dueñas, Gonzalo Isaí Flores-Acosta, Jahaziel Gasperin-Bulbarela, Johanna Bernáldez-Sarabia, Olivia Cabanillas-Bernal, Karla Cervantes-Luévano, Alexei F. Licea-Navarro · 2022 · International Journal of Molecular Sciences
  62. Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2
    Yuichiro Yamamoto, Tetsuya Inoue · 2024 · Biological and Pharmaceutical Bulletin
  63. A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation
    Saskia Catherina Stein, Guido Hansen, George Liam Ssebyatika, L.J. Stroh, Okechukwu Ochulor, Elisabeth Herold, Britta Schwarzloh, Doris Mutschall, Jasmin Zischke, Anne K. Cordes et al. · 2024 · Journal of Virology
  64. Enabling the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants including KP.2
    Chao Su, Juanhua He, Yufeng Xie, Yu Hu, Xin Li, Shitong Qiao, Peipei Liu, Min Huang, Rong Zhang, Liang Wang et al. · 2025 · hLife
  65. Computational insights into the membrane fusion mechanism of SARS-CoV-2 at the cellular level
    Jimin Wang, Federica Maschietto, Matthew J. Guberman‐Pfeffer, Krystle M. Reiss, Brandon Allen, Yong Xiong, Elias Lolis, Víctor S. Batista · 2021 · Computational and Structural Biotechnology Journal
  66. Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein
    Carlos Costa, Arménio Jorge Moura Barbosa, Ana Margarida Gonçalves Carvalho Dias, Ana Cecília A. Roque · 2022 · Biotechnology Advances
  67. SARS-CoV-2 Delta Variant: Interplay between Individual Mutations and Their Allosteric Synergy
    Chun Chan, Yi Song, Zheng Xu, Chun Shang, Ruhong Zhou · 2022 · Biomolecules
  68. A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy
    Lu Monroe Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Yuanfei Zhu, Teng Li, Lu Lu, Junqi Zhang, Heng Yang et al. · 2023 · PLoS Pathogens
  69. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron
    Simon Schröder, Anja M. Richter, Talitha Veith, Jackson Emanuel, Luca Gudermann, Kirstin Friedmann, Lara Maria Jeworowski, Barbara Mühlemann, Terry C. Jones, Marcel A. Müller et al. · 2023 · Virology Journal
  70. Structural insights into SARS-CoV-2 infection and therapeutics development
    Gangyu Sun, Lulu Xue, Qingjing He, Yue Zhao, Wenqing Xu, Zhizhi Wang · 2021 · Stem Cell Research
  71. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters
    Bao-Zhong Zhang, Xiaolei Wang, Shuo-Feng Yuan, Wenjun Li, Y. Dou, V. Poon, C. Chan, Jian-Piao Cai, K. Chik, K. Tang et al. · 2021 · Emerging Microbes and Infections
  72. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
    2023
  73. Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality
    Jule Goike, Ching‐Lin Hsieh, Andrew P. Horton, Elizabeth C. Gardner, Foteini Bartzoka, Nianshuang Wang, Kamyab Javanmardi, Andrew S. Herbert, Shawn A. Abbasi, Rebecca L. Renberg et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Free Energy Simulations of Receptor-Binding Domain Opening of the SARS-CoV-2 Spike Indicate a Barrierless Transition with Slow Conformational Motions
    Victor Ovchinnikov, Martin Karplus · 2023 · The Journal of Physical Chemistry B
  75. Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses
    Megi Rexhepaj, Daniel E. Asarnow, Lisa Perruzza, Young‐Jun Park, Barbara Guarino, Mathew Mccallum, Katja Culap, Christian Saliba, Giada Leoni, Alessio Balmelli et al. · 2024 · Immunity
  76. Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies
    Xuanyu Nan, Yujie Li, Rui Zhang, Ruoke Wang, Niannian Lv, Jiayi Li, Yuanfang Chen, Bini Zhou, Yangjunqi Wang, Ziyi Wang et al. · 2024 · Nature Communications
  77. Cryo-ET of IgG bivalent binding on SARS-CoV-2 provides structural basis for antibody avidity
    Hangping Yao, Yutong Song, Qi Huang, Miaojin Zhu, Jiaming Liang, Zheyuan Zhang, Xiaodi Zhang, Dongyang Dong, Danrong Shi, Zhigang Wu et al. · 2026 · Nature Communications
  78. Predicting high-fitness viral protein variants with Bayesian active learning and biophysics
    Marian Huot, Dianzhuo Wang, Jiacheng Liu, Eugene I. Shakhnovich · 2025 · Proceedings of the National Academy of Sciences
  79. COVID-19 antibody development fueled by HIV-1 bNAb research
    Pilar Mendoza, Julio C. C. Lorenzi, C. Gaebler · 2020 · Current Opinion in HIV and AIDS
  80. Covid-19 vaccination: The pros and cons
    Odangowei Inetiminebi Ogidi, Wonyinbarakemi Ladi Berefagha, Ebifanimi Okara · 2021 · World Journal of Biology Pharmacy and Health Sciences
  81. No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults
    Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, Nareshkumar Poopalasingam, Susanne Detmer, Manuel Koch, Michael Korenkov, Sandro Halwe, Michael Klüver, Veronica Di Cristanziano et al. · 2022 · iScience
  82. Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant
    Gennady M. Verkhivker · 2022 · International Journal of Molecular Sciences
  83. Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants
    Marianna Agudelo, Frauke Muecksch, Dennis J. Schaefer-Babajew, Alice Cho, Justin DaSilva, Eva Bednarski, Víctor Ramos, Thiago Y. Oliveira, Melissa Cipolla, Anna Gazumyan et al. · 2022 · The Journal of Experimental Medicine
  84. Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence
    Kathryn M. Hastie, Xiaoying Yu, Fernanda Ana‐Sosa‐Batiz, Dawid S. Zyla, Stephanie Harkins, Chitra Hariharan, Hal Wasserman, Michelle A. Zandonatti, Robyn Miller, Erin Maule et al. · 2023 · Cell Reports
  85. Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2
    Michael G. Wuo, Amanda E. Dugan, Melanie Halim, Blake Marie Hauser, Jared E. Feldman, Timothy M. Caradonna, Shuting Zhang, Lauren E. Pepi, Caroline G. Atyeo, Stephanie Fischinger et al. · 2023 · ACS Central Science
  86. Topological data analysis of protein structure and inter/intra-molecular interaction changes attributable to amino acid mutations
    Jun Koseki, Shuto Hayashi, Yasuhiro Kojima, Haruka Hirose, Teppei Shimamura · 2023 · Computational and Structural Biotechnology Journal
  87. Exploring cell-free assays for COVID-19 serosurvey
    Lucia Inchauste, Elif Nurtop, Nadége Brisbarre, Läétitia Ninove, Pierre Gallian, Xavier Nicolas de Lamballerie, Stéphane Priet · 2024 · Scientific Reports
  88. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
    Guidenn Sulbarán, Pauline Maisonnasse, Axelle Amen, Grégory Effantin, Delphine Guilligay, Nathalie Dereuddre‐Bosquet, Judith A. Burger, Meliawati Poniman, Marloes Grobben, Marlyse Buisson et al. · 2022 · Cell Reports Medicine
  89. Immune escape facilitation by mutations of epitope residues in RdRp of SARS-CoV-2
    Aayatti Mallick Gupta, Sasthi Charan Mandal, Sukhendu Mandal, J. Chakrabarti · 2022 · Journal of Biomolecular Structure and Dynamics
  90. Asymmetry in icosahedral viruses
    Joyce Jose, Susan L. Hafenstein · 2022 · Current Opinion in Virology
  91. Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD
    Yaozong Chen, Jérémie Prévost, Irfan Ullah, Hugo Romero, Véronique Lisi, William David Tolbert, Jonathan R. Grover, Shilei Ding, Shang Yu Gong, Guillaume Beaudoin-Bussières et al. · 2022 · iScience
  92. But does it work? Improving evaluations of sexuality education.
    Debra W. Haffner, Eva S. Goldfarb · 1997 · PubMed
  93. A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity
    Eric D. Laing, Spencer L. Sterling, Stephanie A Richard, Shreshta Phogat, Emily C Samuels, Nusrat J Epsi, Lianying Yan, Nicole Moreno, Christian L. Coles, Jennifer L. Mehalko et al. · 2020 · medRxiv
  94. A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions
    Eric D. Laing, Spencer L. Sterling, Stephanie A Richard, Nusrat J Epsi, Shreshta Phogat, Emily C Samuels, Lianying Yan, Nicole Moreno, Christian L. Coles, Matthew R. Drew et al. · 2020 · Research Square
  95. Predictive Profiling of SARS-CoV-2 Variants by Deep Mutational Learning
    Joseph M. Taft, Cédric R. Weber, Beichen Gao, Roy A. Ehling, Jiami Han, Lester Frei, Sean W. Metcalfe, Alexander Yermanos, William Kelton, Sai T. Reddy · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  96. COVID-19 mRNA third dose induces a unique hybrid immunity-like antibody response
    Emanuele Andreano, Ida Paciello, Giulio Pierleoni, Giulia Piccini, Valentina Abbiento, Giada Antonelli, Piero Pileri, Noemi Manganaro, Elisa Pantano, Giuseppe Maccari et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques
    Jaclyn A. Kaiser, Christine E. Nelson, Xue-Qiao Liu, Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, Celia Santos, Laura R. H. Ahlers, Richard Herbert, Ian N. Moore et al. · 2024 · Nature Communications
  98. A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein
    S. Schendel, Xiao-Ying Yu, P. Halfmann, J. Mahita, Brendan Ha, K. Hastie, Hao-Yang Li, D. Bedinger, Camille B. Troup, Kan Li et al. · 2025 · Cell Reports
  99. Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals
    Susan L. Uprichard, Amornrat O’Brien, Monika Evdokimova, Cynthia L. Rowe, Cara Joyce, Matthew Hackbart, Yazmin E. Cruz-Pulido, Courtney A. Cohen, Michelle L. Rock, John M. Dye et al. · 2022 · Viruses
  100. Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
    Beatriz Olea, Eliseo Albert, Ignacio Torres, Paula Amat, María José Remigia, Roberto Gozalbo‐Rovira, Jesús Rodríguez‐Díaz, Javier Buesa, María Luisa Blasco, Josep Redón et al. · 2021 · Journal of Clinical Virology